Mesothelioma News and Research

RSS
Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or have been exposed to high levels of asbestos fibers.
Innovative treatment increases survival of people with malignant mesothelioma, trial shows

Innovative treatment increases survival of people with malignant mesothelioma, trial shows

Non-smokers' lung cancer among top five global cancer-related deaths in 2023

Non-smokers' lung cancer among top five global cancer-related deaths in 2023

Basal spot junctions: A new player in epithelial adhesion and hippo signaling

Basal spot junctions: A new player in epithelial adhesion and hippo signaling

Asbestos exposure linked to higher incidence of lung cancers in naval personnel

Asbestos exposure linked to higher incidence of lung cancers in naval personnel

New drug shows promise in killing cancer cells with genetic vulnerability

New drug shows promise in killing cancer cells with genetic vulnerability

Study highlights YB-1 targeting as novel treatment approach for pleural mesothelioma

Study highlights YB-1 targeting as novel treatment approach for pleural mesothelioma

Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

$45M awarded to develop sense-and-respond implant technology for cancer treatment

$45M awarded to develop sense-and-respond implant technology for cancer treatment

Extended pleurectomy decortication plus chemotherapy associated with worse outcomes for mesothelioma patients

Extended pleurectomy decortication plus chemotherapy associated with worse outcomes for mesothelioma patients

Non-invasive breath analysis could improve treatment of malignant pleural mesothelioma

Non-invasive breath analysis could improve treatment of malignant pleural mesothelioma

Lawyer fees draw scrutiny as Camp Lejeune claims stack up

Lawyer fees draw scrutiny as Camp Lejeune claims stack up

HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

HIPEC: A promising treatment for certain patients with Stage IV abdominal cancer

Houston-based cancer survivor donates $10 million to accelerate translational research and clinical trials

Houston-based cancer survivor donates $10 million to accelerate translational research and clinical trials

A review of the risk factors associated with cancer evolution

A review of the risk factors associated with cancer evolution

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients

Persistent tumor mutation burden linked with therapeutic response to immunotherapy

Persistent tumor mutation burden linked with therapeutic response to immunotherapy

Dogs are a better proxy for human health risks, UQ researchers say

Dogs are a better proxy for human health risks, UQ researchers say

Pollutant particles in the air trigger lung cancer in non-smokers

Pollutant particles in the air trigger lung cancer in non-smokers

Comprehensive genetic architecture atlas compiled for mutant RAS genes in cancers

Comprehensive genetic architecture atlas compiled for mutant RAS genes in cancers

“Drug factory” implants show promise in eradicating mesothelioma tumors

“Drug factory” implants show promise in eradicating mesothelioma tumors